drug · small molecule
patient view →SGX-302
Phase 2updated 2mo agoby $SNGX SOLIGENIX, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Unknown, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that